PRAX
Praxis Precision Medicines Inc
295.50$
+3.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Praxis Precision Medicines Inc (PRAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -78 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.9 | -7.9 | -7.7 | -10.0 | -8.4 | -9.9 | -14 | -20 | -26 | -30 | -24 | -45 | -54 | -57 | -45 | -29 | -33 | -31 | -23 | -24 | -21 | -27 | -28 | -56 | -53 | -55 | -65 | -77 | -86 | -78 | -306 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.2 | 0.2 | 0.3 | 0.5 | 0.6 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.1 | 0.1 | 0.1 | -3.5 | 0.0 | 0.0 | -0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 0.1 | 0.1 | 0.3 | 0.2 | 0.1 | 0.3 | 1.0 | 3.8 | 4.7 | 5.4 | 6.5 | 6.1 | 7.9 | 7.6 | 6.7 | 6.4 | 7.6 | 5.8 | 5.8 | 5.7 | 14 | 5.9 | 12 | 8.6 | 8.8 | 7.8 | 7.4 | 9.9 | 17 | 11 | 46 | |
| – | – | 0.4 | 0.4 | 0.3 | 0.4 | 1.1 | 4.0 | 5.1 | 6.2 | 6.6 | 7.2 | 7.9 | 8.0 | 6.7 | 6.4 | 7.6 | 5.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.3 | 0.3 | 2.5 | -2.9 | -0.4 | 1.2 | 1.2 | 1.6 | -3.3 | 0.3 | 13 | 6.6 | 6.1 | -4.8 | -8.0 | 5.7 | -3.1 | -2.7 | -4.4 | -2.8 | 1.7 | 0.7 | -2.2 | -4.9 | 8.7 | 9.4 | 2.2 | 2.1 | -10 | -4.6 | -11 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.5 | 0.5 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.2 | 0.3 | |
| 0.0 | 0.0 | 0.0 | 0.0 | -140 | -140 | -140 | 0.0 | -140 | -24 | 14 | 10 | -8.6 | 35 | 48 | 23 | 34 | 5.0 | – | -0.1 | -91 | -196 | 50 | -11 | -51 | 18 | 50 | -328 | -344 | 11 | -611 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | 0.0 | – | -30 | 0.0 | 0.0 | 30 | 0.3 | 99 | 0.2 | 1.0 | 0.3 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 | 0.0 | – | – | – | – | – | – | – | – | |
| 5.0 | 5.0 | -0.1 | 50 | -30 | 23 | 109 | 202 | 0.1 | 99 | 0.0 | 7.5 | 1.2 | 0.2 | 3.1 | 5.2 | 18 | 69 | -0.3 | 3.9 | 182 | 216 | 1.4 | 114 | 54 | 29 | 6.4 | 613 | 609 | 3.6 | 1,233 | |
| -2.9 | -2.9 | -7.8 | 40 | -45 | 14 | 95 | 182 | -165 | 45 | -11 | -28 | -61 | -22 | 6.4 | -0.8 | 19 | 43 | -23 | -20 | 71 | -6.8 | 24 | 47 | -50 | -8.2 | -7.9 | 208 | 179 | -63 | 316 | |
| -7.9 | -7.9 | -7.7 | -10.0 | -8.4 | -9.9 | -14 | -20 | -26 | -30 | -24 | -45 | -54 | -57 | -45 | -29 | -33 | -31 | -23 | -24 | -21 | -27 | -28 | -56 | -53 | -55 | -65 | -77 | -86 | -78 | -306 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.